Augmented O-GlcNAcylation exacerbates right ventricular dysfunction and remodeling via enhancement of hypertrophy, mitophagy, and fibrosis in mice exposed to long-term intermittent hypoxia
- PMID: 36376492
- DOI: 10.1038/s41440-022-01088-8
Augmented O-GlcNAcylation exacerbates right ventricular dysfunction and remodeling via enhancement of hypertrophy, mitophagy, and fibrosis in mice exposed to long-term intermittent hypoxia
Abstract
Previously, we showed that augmented O-linked N-acetylglucosaminylation (O-GlcNAcylation) mitigates cardiac remodeling in O-GlcNAc transferase-transgenic (Ogt-Tg) mice exposed to acute (2-week) intermittent hypoxia (IH) by suppressing nuclear factor of activated T cells (NFAT) and nuclear factor kappa B (NF-κB) via the O-GlcNAcylation of glycogen synthase kinase 3 beta (GSK-3β) and NF-κB p65. Because this effect is time dependent, we exposed Ogt-Tg mice to IH for 4 weeks (IH4W) in the present study. O-GlcNAcylation was significantly enhanced in Ogt-Tg mice vs. wild-type (WT) mice exposed to normoxia and IH4W. Total O-GlcNAcylation levels were significantly increased in WT and Ogt-Tg mice after IH4W vs. normoxia. After IH4W, Ogt-Tg mice displayed significantly exacerbated signs of cardiac hypertrophy and fibrosis in the right ventricles (RVs) but not the left ventricles (LVs). Echocardiography revealed IH4W-induced right ventricular dysfunction. Phosphorylated GSK-3β levels were increased in Ogt-Tg mice vs. WT mice after IH4W, whereas phosphorylated NF-κB p65 levels were unaffected. Mitophagy, which is associated with cardiac dysfunction, was increased in the RVs of Ogt-Tg mice after IH4W. Furthermore, the levels of phosphorylated dynamin-related protein 1 (p-Drp1) were significantly increased, and the expression of mitofusin-2 (MFN2) was significantly decreased. In human embryonic kidney cells, mitochondrial uncoupler-induced mitochondrial dysfunction was accelerated in Ogt-overexpressing cells. In addition to increasing the levels of phosphorylated Smad2, IH4W promoted cardiac fibrosis in the RVs of Ogt-Tg mice. Thus, augmented O-GlcNAcylation may aggravate IH4W-induced right ventricular dysfunction and remodeling by promoting hypertrophy, mitophagy, and fibrosis via GSK-3β inactivation, an increased p-Drp-1/MFN2 ratio, and Smad2 activation, respectively.
Keywords: Cardiac remodeling; Intermittent hypoxia; O-GlcNAcylation.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Comment in
-
Could the control of O-GlcNAcylation play a key role in cardiac remodeling?Hypertens Res. 2023 Mar;46(3):765-767. doi: 10.1038/s41440-023-01171-8. Epub 2023 Jan 13. Hypertens Res. 2023. PMID: 36635529 No abstract available.
Similar articles
-
Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.Hypertens Res. 2019 Dec;42(12):1858-1871. doi: 10.1038/s41440-019-0311-x. Epub 2019 Aug 13. Hypertens Res. 2019. PMID: 31409917
-
O-GlcNAcylation-induced GSK-3β activation deteriorates pressure overload-induced heart failure via lack of compensatory cardiac hypertrophy in mice.Front Endocrinol (Lausanne). 2023 Mar 22;14:1122125. doi: 10.3389/fendo.2023.1122125. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033243 Free PMC article.
-
Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling.Int J Mol Med. 2015 Jul;36(1):150-8. doi: 10.3892/ijmm.2015.2198. Epub 2015 Apr 24. Int J Mol Med. 2015. PMID: 25936416 Free PMC article.
-
Essential role of O-GlcNAcylation in stabilization of oncogenic factors.Biochim Biophys Acta Gen Subj. 2019 Aug;1863(8):1302-1317. doi: 10.1016/j.bbagen.2019.04.002. Epub 2019 Apr 26. Biochim Biophys Acta Gen Subj. 2019. PMID: 31034911 Review.
-
Increased protein O-GlcNAcYLATION in human placentas from hypertensive pregnancies.Placenta. 2025 May 26:S0143-4004(25)00178-X. doi: 10.1016/j.placenta.2025.05.024. Online ahead of print. Placenta. 2025. PMID: 40436649 Review.
Cited by
-
Decoding glycosylation in cardiovascular diseases: mechanisms, biomarkers, and therapeutic opportunities.Front Pharmacol. 2025 May 19;16:1570158. doi: 10.3389/fphar.2025.1570158. eCollection 2025. Front Pharmacol. 2025. PMID: 40458788 Free PMC article. Review.
-
Stomatin-like protein 2 deficiency exacerbates adverse cardiac remodeling.Cell Death Discov. 2023 Feb 14;9(1):63. doi: 10.1038/s41420-023-01350-z. Cell Death Discov. 2023. PMID: 36788223 Free PMC article.
-
Roles of O-GlcNAcylation in Mitochondrial Homeostasis and Cardiovascular Diseases.Antioxidants (Basel). 2024 May 6;13(5):571. doi: 10.3390/antiox13050571. Antioxidants (Basel). 2024. PMID: 38790676 Free PMC article. Review.
-
Obstructive Sleep Apnea and Hypertensive Heart Disease: From Pathophysiology to Therapeutics.Rev Cardiovasc Med. 2023 Dec 6;24(12):342. doi: 10.31083/j.rcm2412342. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077075 Free PMC article. Review.
References
-
- Holt GD, Snow CM, Senior A, Haltiwanger RS, Gerace L, Hart GW. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol. 1987;104:1157–64. - DOI
-
- Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007;446:1017–22. - DOI
-
- Iyer SP, Hart GW. Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling. Biochemistry. 2003;42:2493–9. - DOI
-
- Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, et al. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation. 2008;117:1172–82. - DOI
-
- Laczy B, Hill BG, Wang K, Paterson AJ, White CR, Xing D, et al. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol. 2009;296:H13–28. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous